DHC (Diversified Healthcare Trust) Risk Assessment


DHC Diversified Healthcare Trust DHC
55 GF Score
Price $9.23
GF Value $3.20
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Diversified Healthcare Trust Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Diversified Healthcare Trust is: High Risk: High uncertainty with risk-return tradeoff.

Diversified Healthcare Trust  (NAS:DHC) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Diversified Healthcare Trust Risk Assessment Related Terms

DHC vs LTC, MPT, SILA: Risk Assessment Comparison

For the REIT - Healthcare Facilities subindustry, Diversified Healthcare Trust's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diversified Healthcare Trust Risk Assessment vs REITs Industry

For the REITs industry and Real Estate sector, Diversified Healthcare Trust's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Diversified Healthcare Trust's Risk Assessment falls into.


DHC
55GF Score
Diversified Healthcare Trust DHC
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Diversified Healthcare Trust (DHC) Overvalued in 2026?

Based on GuruFocus' analysis, Diversified Healthcare Trust stock appears to be overvalued. The current stock price of $9.23 is trading 188.4% above its estimated GF Value™ of $3.20. GuruFocus considers Diversified Healthcare Trust to be Significantly Overvalued.

Key valuation signals for DHC:

  • Risk Assessment:
  • GF Value™: $3.20 vs. price of $9.23 (188.4% above fair value)
  • GF Score™: 55/100 with 7 warning signs

No single metric tells the full story. See the DHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diversified Healthcare Trust Business Description

Industry Real EstateREITs
Other Exchanges SNF:Germany
Address 255 Washington Street, Suite 300, Two Newton Place, Newton, MA, USA, 02458-1634
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.
55GF Score

Get the complete analysis for DHC

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.23
Price
$3.20
GF Value